Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer

Clinical Cancer Research

Volumn 5, Issue 10, 1999, Pages 2840-2847

  Wildi, Stefan ^a   Kleeff, Jörg ^a   Maruyama, Haruhisa ^a   Maurer, Christoph A ^b   Friess, Helmut ^b   Büchler, Markus W ^b   Lander, Arthur D ^a   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20;

ARTICLE; CANCER DIAGNOSIS; COLORECTAL CANCER; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; METASTASIS; NORTHERN BLOTTING; PANCREAS CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

COLORECTAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; PANCREATIC NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032694993     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Eichner, R., Bonitz, P., and Sun, T. T. Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J. Cell. Biol., 98: 1388-1396, 1984.
2. Hatzfeld, M., and Weber, K. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratins: use of site-specific mutagenesis and recombinant protein expression. J. Cell. Biol., 110: 1199-1210, 1990.
3. Steinert, P. M. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer. J. Biol. Chem., 265: 8766-8774, 1990.
4. Moll, R., Franke, W. W., Schiller, D., Geiger, B., and Krepler, R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell, 31: 11-24, 1982.
5. Moll, R., Schiller, D. L., and Franke, W. W. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J. Cell. Biol., 111: 567-580, 1990.
6. Van Muijen, G. N. P., Ruiter, D. J., Franke, W. W., Achtstaetter, T., Haasnoot, W. H. B., Ponec, M., and Warnaar, S. O. Cell type heterogeneity of cytokeratin expression in complex epithelia and carcinomas as demonstrated by monoclonal antibodies specific for cytokeratins nos. 4 and 13. Exp. Cell. Res., 162: 97-113, 1986.
7. Wu, Y. J., Parker, L. M., Binder, N. E., Beckett, M. A., Sinard, J. H., Griffiths, C. T., and Rheinwald, J. G. The mesothelial keratins: a new family of cytoskeletal proteins identified in cultured mesothelial cells and nonkeratinizing epithelia. Cell, 31: 693-703, 1982.
8. Osborn, M., and Weber, K. Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab. Investig., 48: 372-394, 1983.
9. Nagle, R. B. Intermediate filaments: a review of the basic biology. Am. J. Surg. Pathol., 12 (Suppl. 1): 4-16, 1988 .
10. Nagle, R. B. Intermediate filaments. Efficacy in surgical pathologic diagnosis. Am. J. Clin. Pathol., 91 (Suppl. 1): 14-18, 1989 .
11. Moll, R., Loewe, A., Laufer, J., and Franke, W. W. Cytokeratin 20 in human carcinomas. Am. J. Pathol., 140: 427-447, 1992.
12. Fuchs, E., and Green, H. Changes in keratin gene expression during terminal differentiation of the keratinocytes. Cell, 19: 1033-1042, 1980.
13. Franke, W. W., Schiller, D. L., Moll, R., Winter, S., Schmid, E., Engelbrecht, I., Denk, H., Krepler, R., and Plazter, B. Diversity of cytokeratins. Differentiation specific expression of cytokeratin polypeptides in epithelial cells and tissues. J. Mol. Biol., 153: 933-959, 1981.
14. Tseng, S. C. G., Jarvinen, M. J., Nelson, W. G., Huang, J. W., Woodcock-Mitchell, J., and Sun, T. T. Correlation of specific keratins with different types of epithelial differentiation: monoclonal antibody studies. Cell, 30: 361-372, 1982.
15. Fuchs, E., Tyner, A. L., Giudice, G. J., Marchuk, D., Ray-Chaudhury, H., and Rosenberg, M. The human keratin genes and their differential expression. Curr. Top. Dev. Biol., 22: 5-34, 1987.
16. Cooper, D., Schermer, A., and Sun, T. T. Classification of human epithelia and their neoplasma using monoclonal antibodies to keratins: strategies, applications and limitations. Lab. Investig., 52: 243-256, 1985.
17. Moll, R., Zimbelmann, R., Goldschmidt, M. D., Keith, M., Laufer, J., Kasper, M., Koch, P. J., and Franke, W. W. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation (Camb.), 53: 75-93, 1993.
18. Bouwens, L., Lu, W. G., De Krijger, R., and Pipeleers, D. Keratins as markers of duct-to-islet cytodifferentiation in fetal pancreas. Diabetologia, 39: A63, 1996.
19. Bouwens, L., Braet, F., and Heimberg, H. Identification of rat pancreatic duct cells by their expression of cytokeratins 7, 19 and 20 in vivo and after isolation and culture. J. Histochem. Cytochem., 43: 245-253, 1995.
20. Faa, G., Van Eyken, P., Roskams, T., Miyazaki, H., Serreli, S., Ambu, R., and Desmet, V. J. Expression of cytokeratin 20 in developing rat liver and in experimental models of ductular and oval cell proliferation. J. Hepatol., 29: 628-633, 1998.
21. Bouwens, L. Cytokeratins and cell differentiation in the pancreas. J. Pathol., 184: 234-239, 1998.
22. Tot, T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer (Phila.), 85: 171-177, 1999.
23. Lagendijk, J. H., Mullink, H., Van Diest, H., Meijer, G., and Meijer, C. J. L. M. Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry. Hum. Pathol., 29: 491-497, 1998.
24. Maeda, T., Kajiyama, K., Adachi, E., Takenaka, K, Sugimachi, K., and Tsuneyoshi, M. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver. Mod. Pathol., 9: 901-909, 1996.
25. Berezowski, K., Stastny, J. F., and Kornstein, M. J. Cytokeratins 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod. Pathol., 9: 426-429, 1996.
26. Sack, M. J., and Roberts, S. A. Cytokeratins 20 and 7 in the differential diagnosis of metastatic carcinoma in cytologic specimens. Diagn. Cytopathol., 16: 132-136, 1997.
27. Loy, T. S., and Calaluce, R. D. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am. J. Clin. Pathol., 102: 764-767, 1994.
28. Young, R. H., and Hart, W. R. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am. J. Surg. Pathol., 22: 805-815, 1998.
29. Longatto Filho, A., Bisi, H., Alves, V. A., Kanamura, C. T., Oyafuso, M. S., Bortolan, J., and Lombardo, V. Adenocarcinoma in females detected in serous effusions. Cytomorphologic aspects and immunocytochemical reactivity to cytokeratins 7 and 20. Acta Cytol., 41: 961-971, 1997.
30. Ronnett, B. M., Kurman, R. J., Shmookler, B. M., Sugarbaker, P. H., and Young, R. H. The morphologic spectrum of ovarian metastases of appendiceal adenocarcinomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am. J. Surg. Pathol., 21: 1144-1155, 1997.
31. Loy, T. S., Calaluce, R. D., and Keeney, G. L. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod. Pathol., 9: 1040-1044, 1996.
32. Litle, V. R., Warren, R. S., Moore, D., II, and Pallavicini, M. G. Molecular cytogenetic analysis of cytokeratin 20-labeled cells in primary tumors and bone marrow aspirates from colorectal carcinoma patients. Cancer (Phila.), 79: 1664-1670, 1997.
33. Miettinen, M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinoma. Mod. Pathol., 8: 384-388, 1995.
34. Wyld, D. K., Selby, P., Perren, T. J., Jonas, S. K., Allen-Mersh, T. G., Wheeldon, J., and Burchill, S. A. Detection of colorectal cancer in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20. Int. J. Cancer, 79: 288-293, 1998.
35. Bostick, P. J., Chatterjee, S., Chi, D. D., Huynh, K. T., Giuliano, A. E., Cote, R., and Hoon, D. S. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J. Clin. Oncol., 16: 2632-2640, 1998.
36. Soeth, E., Roeder, C., Juhl, H., Krueger, U., Kremer, B., and Kalthoff, H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int. J. Cancer, 69: 278-282, 1996.
37. Soeth, E., Vogel, I., Roeder, C., Juhl, H., Marxsen, J., Krueger, U., Henne-Bruns, D., Kremer, B., and Kalthoff, H. Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res., 57: 3106-3110, 1997.
38. Weitz, J., Kienle, P., Lacroix, J., Willeke, F., Benner, A., Lennert, T., Herfarth, C., and Von Knebel Doeberitz, M. Dissemination of tumor cells in patients undergoing surgery for colorectal cancer. Clin. Cancer Res., 4: 343-348, 1998.
39. Funaki, N. O., Tanaka, J., Ohshio, G., Onodera, H., Maetani, S., and Imamura, M. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients. Br. J. Cancer, 77: 1327-1332, 1998.
40. Futamura, M., Takagi, Y., Koumura, H., Kida, H., Tanemura, H., Shimokawa, K., and Saji, S. Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20. J. Surg. Oncol., 68: 34-40, 1998.
41. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics. CA Cancer J. Clin., 47: 5-27, 1997.
42. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocynate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
43. Korc, M., Chandrasekar, B., Yamanaka, Y., Friess, H., Buechler, M. W., and Beger, H. G. Overexpression of the epidermal growth factor in human pancreatic cancer is associated with concomitant increase in the levels of epidermal growth factor and transforming growth factor α. J. Clin. Investig., 90: 1352-1360, 1992